GI
KNSA icon

GAMMA Investing’s Kiniksa Pharmaceuticals KNSA Stock Holding History

GAMMA Investing’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.5K Buy
1,055
+3
+0.3% +$156 ﹤0.01% 2101
2026
Q1 		$50.7K Sell
1,052
-16
-1% -$709 ﹤0.01% 2170
2025
Q4 		$44.1K Sell
1,068
-58
-5% -$2.33K ﹤0.01% 2152
2025
Q3 		$43.7K Buy
1,126
+150
+15% +$4.87K ﹤0.01% 2087
2025
Q2 		$27K Sell
976
-262
-21% -$6.67K ﹤0.01% 2304
2025
Q1 		$27.5K Buy
1,238
+568
+85% +$11.7K ﹤0.01% 2204
2024
Q4 		$13.3K Sell
670
-171
-20% -$3.9K ﹤0.01% 2466
2024
Q3 		$21K Buy
841
+58
+7% +$1.41K ﹤0.01% 2075
2024
Q2 		$14.6K Sell
783
-71
-8% -$1.33K ﹤0.01% 2048
2024
Q1 		$16.8K Buy
854
+73
+9% +$1.43K ﹤0.01% 1762
2023
Q4 		$13.8K Buy
+781
New +$12.8K ﹤0.01% 1718

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

GAMMA Investing's KNSA Position: Q2 2026 in Review

GAMMA Investing increased its Kiniksa Pharmaceuticals (KNSA) stake by 0.29% in Q2 2026, buying an estimated $156 and bringing the position to 1,055 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

GAMMA Investing first reported a position in KNSA in Q4 2023 and has held it in 11 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • GAMMA Investing held 1,055 shares of Kiniksa Pharmaceuticals worth $67.5K as of Q2 2026.
  • GAMMA Investing bought 3 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $156.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2101 holding.
  • GAMMA Investing first reported a position in Kiniksa Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.